These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11378098)

  • 1. Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist.
    Bouchelouche K; Nordling J; Hald T; Bouchelouche P
    Urology; 2001 Jun; 57(6 Suppl 1):118. PubMed ID: 11378098
    [No Abstract]   [Full Text] [Related]  

  • 2. The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis.
    Bouchelouche K; Nordling J; Hald T; Bouchelouche P
    J Urol; 2001 Nov; 166(5):1734-7. PubMed ID: 11586212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast for symptom control of interstitial cystitis.
    Traut JL; Macdonald ES; Spangler ML; Saxena S
    Ann Pharmacother; 2011 Sep; 45(9):e49. PubMed ID: 21862713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder.
    Çetinel S; Çanıllıoğlu YE; Çikler E; Sener G; Ercan F
    BJU Int; 2011 Apr; 107(8):1320-5. PubMed ID: 20735385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The leukotriene receptor antagonist montelukast and aortic stenosis.
    Bäck M; Yin L; Nagy E; Ingelsson E
    Br J Clin Pharmacol; 2013 Jan; 75(1):280-1. PubMed ID: 22616719
    [No Abstract]   [Full Text] [Related]  

  • 6. Eosinophilic cystitis: successful long-term treatment with montelukast sodium.
    Sterrett S; Morton J; Perry D; Donovan J
    Urology; 2006 Feb; 67(2):423.e19-423.e21. PubMed ID: 16461108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast.
    Hani N; Hartmann K; Casper C; Peters T; Schneider LA; Hunzelmann N; Scharffetter-Kochanek K
    Acta Derm Venereol; 2000 May; 80(3):229. PubMed ID: 10954230
    [No Abstract]   [Full Text] [Related]  

  • 8. Montelukast in chronic graft-versus-host disease: a breath of fresh air?
    Bolaños-Meade J; Vogelsang GB
    Transplantation; 2007 Mar; 83(5):527-8. PubMed ID: 17353767
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of leukotriene receptor antagonists for dysmenorrhea of endometriosis.
    Konno R; Fujiwara H; Suzuki M
    Fam Med; 2004 Jan; 36(1):8-9. PubMed ID: 14710319
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?
    Lipman MC; Carding SK
    AIDS; 2007 Jan; 21(3):383-4. PubMed ID: 17255752
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukotriene D4 inhalation challenge for predicting short-term efficacy of montelukast: a pilot study.
    Guan WJ; Shi X; Zheng JP; Gao Y; Jiang CY; Xie YQ; Liu QX; Zhu Z; Guo E; An JY; Yu XX; Liu WT; Zhong NS
    Clin Respir J; 2015 Jan; 9(1):111-20. PubMed ID: 24506412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of leukotriene receptor antagonists in the therapy of bronchial asthma one year following the introduction of Montelukast. Symposium at Munich, 6 March 1999].
    Pneumologie; 1999 Apr; 53(4 Suppl):1-4. PubMed ID: 10368577
    [No Abstract]   [Full Text] [Related]  

  • 13. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma.
    Lambiase A; Bonini S; Rasi G; Coassin M; Bruscolini A; Bonini S
    Arch Ophthalmol; 2003 May; 121(5):615-20. PubMed ID: 12742837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic oesophagitis: treatment using Montelukast.
    Sinharay R
    Gut; 2003 Aug; 52(8):1228-9. PubMed ID: 12865292
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of delayed pressure urticaria with montelukast.
    Berkun Y; Shalit M
    Allergy; 2000 Feb; 55(2):203-4. PubMed ID: 10726745
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of eosinophilic gastroenteritis with montelukast.
    Neustrom MR; Friesen C
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):506. PubMed ID: 10452782
    [No Abstract]   [Full Text] [Related]  

  • 17. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
    Yanase DJ; David-Bajar K
    J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
    Hoxha M; Rovati GE; Cavanillas AB
    Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
    Angelova-Fischer I; Tsankov N
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of aquagenic pruritus with montelukast.
    Herman-Kideckel SM; Binkley K
    J Cutan Med Surg; 2012; 16(3):151-2. PubMed ID: 22713437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.